Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods.

Burja B, Kuret T, Sodin-Semrl S, Lakota K, Rotar Ž, Ješe R, Mrak-Poljšak K, Žigon P, Thallinger GG, Feichtinger J, Čučnik S, Tomšič M, Praprotnik S, Hočevar A.

Autoimmun Rev. 2018 Feb;17(2):188-194. doi: 10.1016/j.autrev.2017.11.022. Epub 2017 Nov 28. Review.

PMID:
29196244
2.

Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.

Planells-Palop V, Hazazi A, Feichtinger J, Jezkova J, Thallinger G, Alsiwiehri NO, Almutairi M, Parry L, Wakeman JA, McFarlane RJ.

Mol Cancer. 2017 Apr 26;16(1):84. doi: 10.1186/s12943-017-0653-4.

3.

NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.

Deutsch AJA, Rinner B, Pichler M, Prochazka K, Pansy K, Bischof M, Fechter K, Hatzl S, Feichtinger J, Wenzl K, Frisch MT, Stiegelbauer V, Prokesch A, Krogsdam A, Sill H, Thallinger GG, Greinix HT, Wang C, Beham-Schmid C, Neumeister P.

Cancer Res. 2017 May 1;77(9):2375-2386. doi: 10.1158/0008-5472.CAN-16-2320. Epub 2017 Mar 1.

4.

Translin and Trax differentially regulate telomere-associated transcript homeostasis.

Gomez-Escobar N, Almobadel N, Alzahrani O, Feichtinger J, Planells-Palop V, Alshehri Z, Thallinger GG, Wakeman JA, McFarlane RJ.

Oncotarget. 2016 Jun 7;7(23):33809-20. doi: 10.18632/oncotarget.9278.

5.

Comprehensive genome and epigenome characterization of CHO cells in response to evolutionary pressures and over time.

Feichtinger J, Hernández I, Fischer C, Hanscho M, Auer N, Hackl M, Jadhav V, Baumann M, Krempl PM, Schmidl C, Farlik M, Schuster M, Merkel A, Sommer A, Heath S, Rico D, Bock C, Thallinger GG, Borth N.

Biotechnol Bioeng. 2016 Oct;113(10):2241-53. doi: 10.1002/bit.25990. Epub 2016 Apr 29.

6.

miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.

Troppan K, Wenzl K, Pichler M, Pursche B, Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C, Neumeister P, Deutsch A.

Int J Mol Sci. 2015 Aug 5;16(8):18077-95. doi: 10.3390/ijms160818077.

7.

Germline/meiotic genes in cancer: new dimensions.

McFarlane RJ, Feichtinger J, Larcombe L.

Cell Cycle. 2015;14(6):791-2. doi: 10.1080/15384101.2015.1010965. No abstract available.

8.

A novel cohort of cancer-testis biomarker genes revealed through meta-analysis of clinical data sets.

Sammut SJ, Feichtinger J, Stuart N, Wakeman JA, Larcombe L, McFarlane RJ.

Oncoscience. 2014 May 6;1(5):349-359. eCollection 2014.

9.

Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2'-deoxycytidine.

Almatrafi A, Feichtinger J, Vernon EG, Escobar NG, Wakeman JA, Larcombe LD, McFarlane RJ.

Oncoscience. 2014 Nov 10;1(11):745-50. eCollection 2014.

10.

Cancer germline gene activation: friend or foe?

McFarlane RJ, Feichtinger J, Larcombe L.

Cell Cycle. 2014;13(14):2151-2. doi: 10.4161/cc.29661. No abstract available.

11.

CancerEST: a web-based tool for automatic meta-analysis of public EST data.

Feichtinger J, McFarlane RJ, Larcombe LD.

Database (Oxford). 2014 Apr 7;2014(0):bau024. doi: 10.1093/database/bau024. Print 2014.

12.

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.

Deutsch AJ, Rinner B, Wenzl K, Pichler M, Troppan K, Steinbauer E, Schwarzenbacher D, Reitter S, Feichtinger J, Tierling S, Prokesch A, Scheideler M, Krogsdam A, Thallinger GG, Schaider H, Beham-Schmid C, Neumeister P.

Blood. 2014 Apr 10;123(15):2367-77. doi: 10.1182/blood-2013-08-518878. Epub 2014 Feb 19.

13.

Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cells.

El-Heliebi A, Kroneis T, Wagner K, Meditz K, Kolb D, Feichtinger J, Thallinger GG, Quehenberger F, Liegl-Atzwanger B, Rinner B.

PLoS One. 2014 Feb 4;9(2):e87663. doi: 10.1371/journal.pone.0087663. eCollection 2014.

14.

Meta-analysis of expression of l(3)mbt tumor-associated germline genes supports the model that a soma-to-germline transition is a hallmark of human cancers.

Feichtinger J, Larcombe L, McFarlane RJ.

Int J Cancer. 2014 May 15;134(10):2359-65. doi: 10.1002/ijc.28577. Epub 2013 Nov 15.

15.

Chordoma Low-Template Microarray Analysis.

Feichtinger J, El-Heliebi A, Kroneis T, Wagner K, Liegl-Atzwanger B, Leithner A, Thallinger GG, Rinner B.

Biomed Tech (Berl). 2013 Sep 7. pii: /j/bmte.2013.58.issue-s1-M/bmt-2013-4310/bmt-2013-4310.xml. doi: 10.1515/bmt-2013-4310. [Epub ahead of print] No abstract available.

PMID:
24043026
16.

CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data.

Feichtinger J, McFarlane RJ, Larcombe LD.

Database (Oxford). 2012 Dec 15;2012:bas055. doi: 10.1093/database/bas055. Print 2012.

17.

Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes.

Feichtinger J, Aldeailej I, Anderson R, Almutairi M, Almatrafi A, Alsiwiehri N, Griffiths K, Stuart N, Wakeman JA, Larcombe L, McFarlane RJ.

Oncotarget. 2012 Aug;3(8):843-53.

Supplemental Content

Loading ...
Support Center